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Purpose: Patients with COPD show an increase in acute exacerbations (AECOPD) during the 
cold season as well as during heat waves in the summer months. Due to global climate changes, 
extreme weather conditions are likely to occur more frequently in the future. The goal of this 
study was to identify patient groups most at risk of exacerbations during the four seasons of 
the year and to determine at which temperature threshold the daily hospital admissions due to 
AECOPD increase during the summer.
Patients and methods: We analyzed retrospective demographic and medical data of 990 
patients, who were hospitalized for AECOPD in Berlin, Germany. The cases were grouped 
into the following cohorts: “spring” (admission between March and May), “summer” (June – 
August), “autumn” (September – November), and “winter” (December – February). AECOPD 
hospital admissions from 2006 and 2010 were grouped into a “hot summer” cohort and cases 
from 2011 and 2012 into a “cold summer” data-set. Climate data were obtained from the Ger-
man Meteorological Office.
Results: Patients hospitalized for a COPD exacerbation during winter were significantly older 
than summertime patients (P=0.040) and also thinner than patients exacerbating in spring 
(P=0.042). COPD exacerbations during hot summer periods happened more often to patients with 
a history of myocardial infarction (P=0.014) or active smokers (P=0.011). An AECOPD during 
colder summers occurred in patients with a higher Charlson index, who suffered in increased 
numbers from peripheral vascular diseases (P=0.016) or tumors (P=0.004). Summertime hospital 
admissions increased above a daily minimum temperature of 18.3°C (P=0.006).
Conclusion: The identification of COPD patient groups most at risk for climate related exac-
erbations enables climate-adapted prevention through patient guidance and treatment. In view 
of global climate changes, discovering vulnerabilities and implementing adaptive measures 
will be of growing importance.
Keywords: COPD, acute exacerbation, seasonal phenotype, urban heat island, heat stress, 
climate change
Introduction
Patients with COPD show an increase in acute exacerbations (AECOPD) during 
the cold season1–3 as well as during heat waves in the summer months.4 A study by 
Mann et al found that higher mean outdoor temperatures, combined with a rise in 
barometric pressure, cause increased morning dyspnea in patients with COPD.5 Other 
studies have demonstrated an increase in hospital admissions due to exacerbations on 
days with high mean temperatures as well as high diurnal temperature ranges.6–8 Due 
to the global climate changes, extreme weather conditions are likely to occur more 
frequently in the future.9 It is, therefore, important to understand the vulnerability of 
COPD patients to climate.
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The relationship between climate and mortality has 
already been investigated in several studies.10–14 For example, 
Zanobetti et al calculated an increased mortality hazard ratio 
for COPD patients aged over 65 years exposed to a high vari-
ability in summertime temperatures.10 The study focused on 
the standard deviation of summer temperatures, but did not 
discriminate between temperatures higher or lower than the 
average. Petkova et al analyzed urban heat-related mortality 
in New York City and concluded that demographic changes 
and the population’s adaptation to heat have a great influence 
on future mortality risk.14 They found a rapid adaptation to 
heat since the 1970s, possibly due to increased access to air 
conditioning.
It was the goal of our study to explore the relationship 
between climate and morbidity of COPD patients in an urban 
environment. As a measure for COPD morbidity, we chose 
hospitalization due to AECOPD.
The purpose of this study was three-fold:
 Analyze the characteristics of patients whose admissions 
occurred during spring, summer, autumn, and winter to 
potentially identify a group most at risk of climate-related 
exacerbations, so that they could be targeted for adapted 
patient guidance and treatment,
 Determine the temperature threshold at which daily hos-
pital admissions due to AECOPD increase above normal 
during the summer,
 Compare patient characteristics and AECOPD hospital 
admission rates between summers with outdoor tempera-
tures above or below the decade’s average.
Patients and methods
Patients and data collection
The study population was a consecutive sample of patients 
hospitalized for exacerbation of COPD, defined as Inter-
national Classification Code-10 German Modification: 
J44.00-J44.99, with a main or secondary entry mentioning 
exacerbation. Demographic and medical data were retro-
spectively obtained from electronic patient records and paper 
notes of the Vivantes Hospitals in Berlin, Germany. The 
study was approved by the Ethics Committee of the Charité – 
Universitätsmedizin Berlin (EA1/199/13). Patients’ consent 
to retrospectively review their medical records was not 
required by the ethics committee, because section 25 of the 
Berlin Hospital Law (Berliner Landeskrankenhausgesetz) 
allows the usage of hospital patient data for research pur-
poses after anonymization. All patient data were treated 
confidentially and anonymized prior to data analysis. The 
Charlson Index was used as a measure of the patients’ 
comorbidities.15,16 To avoid the issues caused by multiple 
statistical analyses run on the same dataset, we selected 
separate cohorts for the analysis of different summer periods 
and seasons of the year. The cohort for the comparison of hot 
and cold summer periods consisted of patients who visited 
the Vivantes Hospital in the district of Neukölln in 2006, 
2010, 2011, and 2012. Patients for the analysis by season 
were admitted to the Vivantes Hospital in the Friedrichshain 
district in 2012. Figure 1 illustrates the time span and number 
of patients included in the different datasets.
environmental variables
Climate data on the daily minimum, mean, and maximum 
temperatures, air pressure, and air humidity were obtained 
from the meteorological station at Berlin-Tempelhof airport, 
available online through the website of the German Meteoro-
logical Office (Deutscher Wetterdienst, www.dwd.de). The 
meteorological station is located in the urban area of Berlin 
48 m above the sea level at 52.47°N and 13.4°E.
statistical analysis
The statistical analysis was performed with IBM SPSS 
Statistics 25 (IBM Corporation, Armonk, NY, USA), and 
GraphPad Prism 7 (GraphPad Software Inc., La Jolla, CA, 
USA). As the date of symptom onset was unknown, we chose 
the hospital admission date as a measure of acute COPD 
exacerbation. A lag day analysis served to evaluate possible 
delays between symptom onset and hospitalization. Due to 
the anonymized patient data, multiple visits by the same 
patient occurred as separate cases in the datasets.
The AECOPD cases of the “analysis by season” dataset 
(see Figure 1) were grouped into the four cohorts “spring” 
(admission between March 1st and May 31st), “summer” 
(June 1st to August 31st), “autumn” (September 1st to 
November 30th), and “winter” (December 1st to February 
29th). Between 2005 and 2014, the average temperature 
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Vulnerability of COPD patient groups to urban climate
summer periods of 2006 and 2010 had hotter average tem-
peratures (20.3°C, one sample t-test, P,0.001), while 2011 
and 2012 featured colder summers (18.6°C, one sample t-test, 
P=0.009). We therefore grouped AECOPD hospital admis-
sions from 2006 and 2010 in a “hot summer” cohort and cases 
from 2011 and 2012 in the “cold summer” group.
For statistical analysis, continuous variables of two 
groups were compared using Mann–Whitney U tests and 
nominal variables using Fisher’s exact tests or chi-squared 
tests. Comparisons between three or more groups were made 
using Kruskal-Wallis tests for continuous variables and 
with chi-square tests for nominal variables. Dunn’s multiple 
comparison test was used for post hoc tests. The relationship 
between hospital admissions per day due to AECOPD and 
climate variables was examined with Poisson regression 
analysis. Corresponding trajectories were calculated with 
a locally weighted scatter plot smoothing method (Loess), 
using a tri-weight function. This function allocates the least 
weight to outlying data points. A P-value below or equal to 
0.05 was considered statistically significant.
Results
Characteristics of patients with 
exacerbations during spring, summer, 
autumn, and winter
Table 1 summarizes the data collected for 427 patients 
who suffered from a COPD exacerbation, sorted by sea-
son. Kruskal-Wallis tests revealed significant differences 
between seasons in terms of patients’ age (P=0.018) and 
BMI (P=0.050). Figure 2 shows that patients with a COPD 
exacerbation during winter were significantly older than 
summertime patients (Dunn’s multiple comparison test, 
P=0.040). Patients hospitalized for AECOPD during winter 
were also significantly thinner than patients exacerbating in 
spring (Dunn’s multiple comparison test, P=0.042).
Comparison of hospital admissions 
due to aeCOPD between “hot” and 
“cold” summers
More patients with AECOPD were admitted to a hospital 
per day during the colder summers of 2011 and 2012 than 
in the hotter summers of 2006 and 2010 (Mann–Whitney 
Table 1 Comparison of patient characteristics and climate variables by season in the year 2012
Parameter Spring Summer Autumn Winter Total P-value
admissions, n 120 90 109 108 427 –
Male, n (%) 61 (50.8%) 54 (60%) 72 (66.1%) 66 (61.1%) 253 (59.3%) 0.123
Female, n (%) 59 (49.2%) 36 (40%) 37 (33.9%) 42 (38.9%) 174 (40.7%) 0.123
age, years, mean ± sD 72.8±11.1 69.3±11.5 70.9±9.9 72.7±12 71.4±11.4 0.018*
BMI, kg/m2, mean ± sD 27.6±8 25.9±6.9 27.0±8.3 24.6±6.5 26.4±7.6 0.050*
smoker, n (%) 37 (39.8%) 34 (44.7%) 40 (47.1%) 38 (46.3%) 149 (44.3%) 0.960
Former smoker, n (%) 52 (55.9%) 38 (50%) 41 (48.2%) 41 (50%) 172 (51.2%) 0.960
non-smoker, n (%) 4 (4.3%) 4 (5.3%) 4 (4.7%) 3 (3.7%) 15 (4.5%) 0.960
Pack years, mean ± sD 43.4±27.4 43.3±23 46.9±28.2 42.2±28.5 44.1±26.8 0.633
FeV1, %, mean ± sD 36.6±15.8 37.4±19.7 37.1±15.6 37.2±16.3 39.5±16.9 0.937
gOlD I or II, n (%) 22 (20.8%) 17 (20.3%) 20 (20%) 16 (16.3%) 75 (19.3%) 0.889
gOlD III, n (%) 38 (35.8%) 24 (28.6%) 33 (33%) 36 (36.7%) 131 (33.8%) 0.889
gOlD IV, n (%) 46 (43.4%) 43 (51.2%) 47 (47%) 46 (46.9%) 182 (46.9%) 0.889
With lTOT, n (%) 40 (71.4%) 24 (63.2%) 40 (58.8%) 36 (69.2%) 140 (65.1%) 0.454
Without lTOT, n (%) 16 (28.6%) 14 (36.8%) 28 (41.2%) 16 (30.8%) 75 (34.9%) 0.454
Charlson Index, mean ± sD 3.1±1.8 2.9±2 2.9±1.8 2.8±1.7 2.9±1.8 0.285
Coronary heart disease, n (%) 31 (25.8%) 22 (24.4%) 25 (22.9%) 39 (36.1%) 117 (27.4%) 0.392
length of stay, days, mean ± sD 11.0±7.8 10.0±6.5 11.5±8.7 10.3±8.1 10.7±7.8 0.587
admissions/day, mean ± sD 1.3±1.3 1.0±0.9 1.2±1.1 1.2±1.1 1.2±1.1 0.520
Tmean, °C, mean ± sD 11.3±5.5 18.5±3.4 10.4±5.1 0.7±5.6 10.2±8.0 ,0.001***
Tmax, °C, mean ± sD 16.2±6.6 23.2±4.3 14.3±6.3 3.1±5.5 14.2±9.2 ,0.001***
Tmin, °C, mean ± sD 6.2±4.8 13.8±2.9 6.6±4.4 −2.0±6.2 6.2±7.3 ,0.001***
ΔT, °C, mean ± sD 10.0±4.0 9.4±3.0 7.6±3.4 5.1±2.3 8.1±3.7 ,0.001***
air pressure, hPa, mean ± sD 1,009.9±9.9 1,008.8±5.0 1,007.9±7.7 1,011.7±11.8 1,009.6±9.1 0.155
air humidity, %, mean ± sD 64.4±11.4 69.4±10.3 78.9±9.8 82.9±8.7 73.9±12.5 ,0.001***
Notes: *P,0.05; ***P,0.001.
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U test, P=0.006). Table 2 lists the patient characteristics 
that were compared. We found significant differences in the 
patients’ Charlson index (Mann–Whitney U test, P=0.002) 
and smoking status (chi-squared test, P=0.016) between 
the hot and cold summer seasons. Table 3 illustrates the 
comorbidities present in more detail. Patients with COPD 
exacerbations during hot summer periods more often had a 
prior myocardial infarction (Fisher’s exact test, P=0.014). An 
AECOPD during colder summers occurred in patients with 
a higher Charlson index, in patients who were more likely 
to have a history of peripheral vascular diseases (Fisher’s 
exact test, P=0.016) or in patients with tumors (Fisher’s 
exact test, P=0.004). A closer inspection of the smoking 
status revealed that, especially in hot summers, more active 
smokers developed an AECOPD than former smokers 
(Fisher’s exact test, P=0.011). In 2006, which included the 
hottest summer period we investigated, 72% of the patients 
with a COPD exacerbation were active smokers, while only 
18% were former smokers.
Figure 3 illustrates the results of a Poisson regression 
analysis. During hot summer seasons, hospital admissions 
per day due to AECOPD increased if the daily minimum 
outdoor temperature surpassed 18.3°C (Poisson regression 
analysis, P=0.006). In the colder summers, the best fit for a 
threshold temperature was 17.4°C, but did not reach statisti-
cal significance (Poisson regression analysis, P=0.322). The 
inclusion of other climate variables like air pressure and air 
humidity into the Poisson regression model resulted in no 
statistically significant improvement.
Figure 4 shows an analysis of the outdoor temperatures for 
the 7 days before three or more hospital admissions per day 
occurred. Neither in the colder summers, nor in the hotter sum-
mers did the temperatures show a statistically significant differ-

























Figure 2 Differences in the age and BMI of patients with aeCOPD in relation to the season.
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Vulnerability of COPD patient groups to urban climate
Discussion
Our findings that patients hospitalized for AECOPD during 
winter were significantly older and thinner than patients 
exacerbating in the other seasons could be influenced by 
hospitals reaching capacity limits. Increased patient loads, 
eg, during influenza epidemics, could influence emergency 
departments to preferentially admit only the older, frailer 
patients. We found no difference in GOLD stage distribu-
tion between the seasons (P=0.962) which suggests that 
the decision to admit a patient was clinically appropriate 
and unbiased by consideration of frailty. Our results are in 
accordance with a study from Tseng et al which found evi-
dence that cold temperatures significantly affect the COPD 
exacerbation rate of elderly patients in Taiwan.1 Almagro 
et al also observed AECOPD patients in Barcelona, Spain 
to be older during winter.17 A possible explanation could be 
a lowered resilience to cold stress in elderly COPD patients. 
Holmér stated that the progressive degradation of physiologi-
cal functions in elderly people increases the risk of harmful 
effects of cold exposure.18
Another result of our study was that more patients with 
AECOPD were admitted to an urban hospital per day dur-
ing the colder summers we analyzed. This is in concordance 
with the observation of Gasparrini et al that milder but 
non-optimum weather contributes more to mortality risk than 
extreme temperatures.12 The adaptation capability of German 
COPD patients to heat stress could be modified in cold sum-
mer periods. Thermoregulatory response improves with 
repeated heat exposure and even passive exposure to heat, 
without any accompanying exercise, results in adaptation.19,20 
Multiple heat waves during the hot summers could have 
improved the thermoregulatory response of the patients, 
leading to less hospital admissions than in the colder sum-
mers. An investigation of heat-related emergency hospitaliza-
tion in the USA by Anderson et al revealed a significantly 
higher hospitalization risk in counties with cooler average 
summer temperatures. The association between temperature 
and hospital admissions was strongest on the same day, but 
still present 1 day after exposure.6 Similar to the results of 
Anderson et al, we found no statistically significant effect of 
lag days. This means that the delay between exposure to heat 
stress, occurrence of AECOPD, and hospital admission was 
not greater than 24 hours. For patients in Berlin, the capital 
of Germany, this seems feasible. Multiple hospitals are 
available within a short traveling distance of every inhabit-
ant, with emergency departments open 24 hours every day. 
Table 2 Comparison of aeCOPD patient characteristics between hot and cold summers
Parameter Hot summers Cold summers P-value
admissions, n 250 313 –
Male, n (%) 129 (51.6%) 158 (50.5%) 0.800
Female, n (%) 121 (48.4%) 155 (49.5%) 0.800
age, years, mean ± sD 70±11 71±11 0.530
BMI, kg/m2, mean ± sD 25.3±6.6 25.6±6.4 0.611
smoker, n (%) 82 (58.2%) 112 (47.1%) 0.016*
Former smoker, n (%) 47 (33.3%) 114 (47.9%) 0.016*
non-smoker, n (%) 12 (8.5%) 12 (5.0%) 0.016*
Pack years, mean ± sD 51.1±32.6 48.8±26.3 0.858
FeV1, %, mean ± sD 39.7±15.2 39.5±15.0 0.852
gOlD I or II, n (%) 42 (24.4%) 54 (19.3%) 0.367
gOlD III, n (%) 80 (46.5%) 146 (52.1%) 0.367
gOlD IV, n (%) 50 (29.1%) 80 (28.6%) 0.367
With lTOT, n (%) 71 (82.6%) 125 (83.3%) 0.859
Without lTOT, n (%) 15 (17.4%) 25 (16.7%) 0.859
Charlson Index, mean ± sD 2.6±1.8 3.1±2.0 0.002**
length of stay, days, mean ± sD 8.3±5.1 8.3±6.0 0.353
admissions/day, mean ± sD 1.4±1.2 1.7±1.3 0.006**
Tmean, °C, mean ± sD 20.3±4.3 18.6±3.0 ,0.001***
Tmax, °C, mean ± sD 25.4±5.2 23.3±4.0 ,0.001***
Tmin, °C, mean ± sD 14.9±3.5 14.0±2.5 0.003**
ΔT, °C, mean ± sD 10.5±3.4 9.3±3.1 ,0.001***
air pressure, hPa, mean ± sD 1,009.3±6.1 1,008.0±5.5 0.059
air humidity, %, mean ± sD 62.8±14.3 67.8±10.9 ,0.001***
Notes: *P,0.05; **P,0.01; ***P,0.001.
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Table 3 Comparison of aeCOPD patient comorbidities between hot and cold summers
Comorbidity Hot summers Cold summers P-value
Coronary heart disease 83 (33.2%) 100 (31.9%) 0.786
Myocardial infarction 45 (17.6%) 33 (10.5%) 0.014*
Congestive heart failure 62 (24.8%) 100 (31.9%) 0.075
Peripheral vascular disease 19 (7.6%) 45 (14.4%) 0.016*
Cerebrovascular disease 21 (8.4%) 39 (12.5%) 0.132
Dementia 11 (4.4%) 20 (6.4%) 0.355
Chronic pulmonary diseasea 250 (100%) 313 (100%) –
Connective tissue disease 0 (0%) 0 (0%) –
Ulcer disease 12 (4.8%) 13 (4.2%) 0.837
renal disease 37 (14.8%) 65 (20.8%) 0.078
liver disease 4 (1.6%) 12 (3.8%) 0.131
Diabetes 52 (20.8%) 85 (27.1%) 0.093
hemiplegia 4 (1.6%) 6 (1.9%) 1.000
any tumor 21 (8.4%) 53 (17.0%) 0.004**
leukemia 2 (0.8%) 4 (1.3%) 0.698
lymphoma 3 (1.2%) 1 (0.3%) 0.328
aIDs 0 (0%) 0 (0%) –
Notes: *P,0.05; **P,0.01; aInclusion criterion.
Another explanation why the study did not reveal significant 
effects of lag days could be the limited amount of data from 
the 4 years. Time series analyses to detect lag day effects 
mostly investigate time spans of 10 years. For example, 
Scherer et al analyzed data from 2001 to 2010 and discovered 
that heat-stress related mortality in Berlin correlated best with 
the mean daily air temperature of five lag days.11 The limited 
power of our study could also be the reason why we did not 
find a threshold temperature with statistical significance for 
increased hospital admissions in colder summers. The daily 
minimum temperature in the cold summers of 2011 and 2012 
surpassed the best fitting temperature threshold of 17.4°C 
only on 19 days. Nevertheless, the determined threshold for 
hot summer seasons, a daily minimum outdoor temperature of 
18.3°C, can now be used to implement warning mechanisms 
for COPD patients.
In the cohorts we investigated, patients suffered more 
often from an AECOPD during hot summer periods if they 
had a history of myocardial infarction or were active smokers. 
An AECOPD during colder summers occurred more often in 
patients with a higher Charlson index, peripheral vascular dis-
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Figure 4 Temperature analysis on the days preceding an increase in hospital admissions.
Notes: The figures show the daily minimum outdoor temperatures 1 week before an increase in hospital admissions to three or more AECOPD patients per day. The left 
column displays the results for hot summers, the right column for cold summers. red and blue dots represent the recorded minimum outdoor temperatures. The number 
of admissions per day are shown as black dots. all trajectories were calculated with a locally-weighted scatter plot smoothing method. The black trajectories illustrate the 
daily admissions due to aeCOPD, the red and blue curves represent minimum outdoor temperatures. 
Abbreviation: Tmin, daily minimum temperature.
Figure 3 Increase in hospital admissions per day in relation to the minimum outdoor temperature.
Notes: The number of hospital admissions per day due to aeCOPD are displayed as diamond markings. The trajectories were calculated using a locally-weighted scatter plot 
smoothing method. a vertical line marks the threshold temperatures for increased hospital admissions during the summer as calculated by Poisson regression analysis.


















studies. In a Dutch cohort, Westerik et al found associations 
between frequent COPD exacerbations and inter alia heart 
failure, pulmonary cancer, and peripheral vascular disease.21 
A prospective cohort study in Spain revealed factors associ-
ated with frequent exacerbations to be inter alia the Charlson 
Index and smoking.22 During summer, the exposure to heat 
causes an increased cardiovascular strain.23 Patients with a 
myocardial infarction history or a peripheral vascular disease 
could be more vulnerable to a summertime AECOPD due to 
a reduced adaptive capacity to the increased cardiovascular 
stress. The adaptive capacity could be further limited by the 
vasoconstrictive effects of tobacco smoking.24 Patients with 
a tumor or a high Charlson Index could be more vulnerable 
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The retrospective design and the usage of anonymized 
patient data put some limitations on the study results. Due 
to anonymization, multiple hospital admissions of the same 
patient occurred as separate cases in the dataset. This could 
potentially influence the results. Other potential confound-
ers that were not analyzed are exposure to air pollutants, 
socioeconomic status, and possible fluctuations in the urban 
population due to seasonal travelings. To confirm and expand 
the results of our analysis, a prospective study, that includes 
cohorts with and without the seasonal AECOPD risk factors 
we have identified, should be performed.
Conclusion
The identification of COPD patient groups most at risk of 
climate related exacerbations enables climate-adapted pre-
vention through patient guidance and treatment. In view of 
the global climate changes, discovering vulnerabilities and 
implementing adaptive measures is of growing importance.
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